| 摘要 |
Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.
|
| 申请人 |
MERCK & CO., INC.;CHEN, DAVID;FRANKLIN, CHRISTOPHER, L.;GUZZO, PETER, R.;LIN, LINUS, S.;LIU, JIAN;LO, MICHAEL, M.-C.;NARGUND, RAVI, P.;SEBHAT, IYASSU, K. |
发明人 |
CHEN, DAVID;FRANKLIN, CHRISTOPHER, L.;GUZZO, PETER, R.;LIN, LINUS, S.;LIU, JIAN;LO, MICHAEL, M.-C.;NARGUND, RAVI, P.;SEBHAT, IYASSU, K. |
